Maria Dmitrievna Yurkanova

Ms. Maria Dmitrievna Yurkanova

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2026 in Cells
Verified
Journal Article
Open access
PDF file
TKTimofey Klyucherev
Timofey Klyucherev
MYMaria Dmitrievna Yurkanova
Maria Dmitrievna Yurkanova
DRDaria P. Revokatova
Daria P. Revokatova
DCDmitriy A. Chevalier
Dmitriy A. Chevalier
VSVsevolod V. Shishkov
Vsevolod V. Shishkov
PTPeter S. Timashev
Peter S. Timashev
Macrophages play a crucial role in regulating immune responses, inflammation, and tissue repair. Depending on environmental cues, they polarize into pro-inflammatory M1 or anti-inflammatory, pro-regenerative M2 phenotypes. Extracellular vesicles (EVs) derived from mesenchymal stem/stromal cells (MSCs) have emerged as key mediators of intercellular communication and immune modulation. This study investigates the effects of matrix-bound vesicles (MBVs) and small extracellular vesicles (sEVs) derived from human umbilical cord MSCs (UC-MSCs) on human monocyte-derived macrophages (MDMs) in vitro. Both MBVs and sEVs reduced pro-inflammatory activation of M1 macrophages, downregulating the expression of CXCL10 and CD86 while increasing the M2 marker CD206. MBVs exerted a stronger suppressive effect on M1 MDM phenotype markers as well as on STAT1, STAT2, and IRF9 mRNA levels in M1 macrophages, indicating the inhibition of the JAK/STAT1 signaling pathway involved in the pro-inflammatory activation of macrophages. Functionally, both vesicle types enhanced phagocytosis of FITC-labeled E. coli by M1 and M0_GM macrophages, promoting a shift toward an M2-like phenotype. Moreover, MBVs and sEVs attenuated reactive oxygen species (ROS) production, with sEVs showing a more pronounced effect both on ROS generation and on the expression of NOX2 complex subunits (p47^phox, p67^phox) in M1 macrophages. These findings demonstrate that MBVs and sEVs from UC-MSCs possess distinct yet complementary immunomodulatory and antioxidant properties on MDMs, suggesting their potential as promising cell-free therapeutic agents for inflammatory and degenerative diseases.

Verified
Journal Article
Open access
PDF file
TKTimofey Klyucherev
Timofey Klyucherev
MPMaria A. Peshkova
Maria A. Peshkova
MYMaria Dmitrievna Yurkanova
Maria Dmitrievna Yurkanova
NKNastasia V. Kosheleva
Nastasia V. Kosheleva
ASAndrey A. Svistunov
Andrey A. Svistunov
PTPeter S. Timashev
Peter S. Timashev
Inflammatory arthritis, including rheumatoid arthritis (RA) and osteoarthritis (OA), is a group of degenerative joint diseases that result in reduced mobility and a prevalent cause of disability. Despite differing etiologies, both conditions involve inflammation, affecting only the joints in OA and systemic in RA due to its autoimmune nature. Regenerative medicine offers promising alternatives, with a focus on the therapy with mesenchymal stem cell (MSC) and their secreted extracellular vesicles (EVs). MSC-derived EVs have shown great potential in modulating inflammatory pathways and promoting tissue repair in the preclinical models of RA and OA. Additionally, EVs from immune cells exhibit strong anti-inflammatory effects, reducing cartilage and bone degeneration. This review highlights the recent progress in MSC-based and EV-based therapies for OA and RA, discussing the bioengineering approaches that enhance the therapeutic efficacy, stability, and targeting of EV. It also addresses the major challenges in translating EV therapy from the laboratory to clinical practice and discusses strategies to overcome these obstacles in the treatment of inflammatory arthritis.

4 May 2025 in Free Radical Research
Verified
Journal Article
Closed access
MYMaria Dmitrievna Yurkanova
Maria Dmitrievna Yurkanova
NKNastasia V. Kosheleva
Nastasia V. Kosheleva
ATArina A. Teplova
Arina A. Teplova
PTPeter S. Timashev
Peter S. Timashev
IVIrina I. Vlasova
Irina I. Vlasova
Macrophages and neutrophils are the main immune cells of the acute stage of inflammation. Upon their activation, membrane-bound NADPH oxidase produces superoxide anion radical, which is converted to H2O2 by superoxide dismutase (SOD). In this study, we compared the production of hydrogen peroxide by two phenotypes of pro-inflammatory human M1 macrophages and neutrophils activated with phorbol-12-myristate 13-acetate. Macrophages were obtained from blood monocytes (monocyte-derived macrophages (MDM)) differentiated into MDM using GM- or M-CSF growth factors and polarized into the M1 state, receiving GM_M1, M_M1, respectively. The total level of H2O2 production measured in the presence of horseradish peroxidase differed significantly between two types of macrophages. Only GM_M1 macrophages had a level of H2O2 production comparable to neutrophils. GM_M1 appear at the site of inflammation after neutrophils, they continue the work of neutrophils in creating a pro-inflammatory environment: they produce several times more H2O2 and pro-inflammatory cytokines than M_M1, which arrive at inflammatory site later. Upon activation, MDM_M1 formed big blot-like and smaller dense spheroid-like aggregates. Activated neutrophils secrete the enzyme myeloperoxidase (MPO), which synthesizes the very potent oxidant hypochlorous acid (HOCl) only in the presence of H2O2. Neutrophils are short lived cells, MPO can use H2O2 produced by activated cultured MDM to synthesize HOCl at physiologically relevant concentrations to prolong oxidative stress.

23 April 2024 in Russian Journal of Human Reproduction
Verified
Journal Article
Closed access
LAL.V. Adamyan
L.V. Adamyan
LPLaura Pivazyan
Laura Pivazyan
MYMaria Dmitrievna Yurkanova
Maria Dmitrievna Yurkanova
KMK.S. Mailova
K.S. Mailova
ASA.A. Stepanian
A.A. Stepanian
Iron is a vital microelement that is involved in many processes to keep the body healthy. When iron accumulates in excess, reactive oxygen species formation, oxidative stress and cell and tissue damage occur. Ferroptosis is the new form of programmed cell death associated with iron-dependent lipid peroxidation, which occurs when iron metabolism and antioxidant systems are impaired. This process is currently attracting much attention in the study of the mechanisms of many diseases, as well as in the search for new methods of their treatment. Recent studies have emphasized the regulatory mechanisms of ferroptosis in pathological conditions such as premature ovarian insufficiency, endometriosis, intrauterine and peritoneal adhesions. However, the role and mechanisms of ferroptosis in these diseases have not been fully elucidated. Thus, our review reveals the mechanisms of ferroptosis, progress in research on its impact on the development of diseases of the female reproductive system, and currently known methods and markers for its detection. Objective. To identify the role of ferroptosis and iron overload in reproductive medicine, in particular in endometriosis, adhesions and premature ovarian insufficiency, and to describe the molecular mechanisms of ferroptosis involved in the development and progression of these diseases in order to find new methods of their treatment and diagnosis.

1 July 2025 in Russian Journal of Human Reproduction
Verified
Journal Article
Closed access
LAL.V. Adamyan
L.V. Adamyan
IMI.Y. Malyshev
I.Y. Malyshev
LPLaura Pivazyan
Laura Pivazyan
MYMaria Dmitrievna Yurkanova
Maria Dmitrievna Yurkanova
KMK.S. Mailova
K.S. Mailova
ASA.A. Stepanyan
A.A. Stepanyan
The aim of this review is to analyse contemporary scientific evidence concerning the role and significance of macrophage polarisation in the pathogenesis of endometriosis. Particular emphasis is placed on the molecular and cellular mechanisms that regulate macrophage phenotypic differentiation and on how these cells sustain inflammation, angiogenesis, fibrosis and immune tolerance within the peritoneal cavity. Promising research avenues for identifying potential targets that could underpin novel diagnostic approaches and innovative targeted therapies for endometriosis are also examined. A comprehensive search was conducted in PubMed, Scopus, Web of Science and Google Scholar, and 93 in-vitro, in-vivo and clinical studies were included in the final analysis. Peritoneal fluid from patients is characterised by the accumulation of haemolytic iron, heightened oxidative stress and oestrogen-dependent hypersecretion of IL-6, IL-8 and CCL-2, which collectively drive macrophages towards a pro-angiogenic M2 phenotype. M2 macrophages secrete VEGF-A, TGF-β1, MMP-2/-9, IL-10 and neurotrophic factors, thereby exacerbating angiofibrogenesis, promoting neuro-vascular invasion and suppressing clearance of ectopic endometrium via the CD47-SIRPα pathway. Exosomes released by stromal cells of ectopic lesions, enriched with miR-301a-3p, LGMNP1 and lncRNA CHL1-AS1, activate the PI3K/AKT, STAT3 and TGF-β/Smad cascades, further reinforcing M2 polarisation, while metabolic reprogramming (the lactate-METTL3-Trib1 axis and succinate accumulation) coupled with reduced HO-1 expression sustains chronic inflammation. Pre-clinical data indicate that macrophage reprogramming using niclosamide, mifepristone, engineered extracellular vesicles, OMV-based nanoparticles or inhibitors of the lactate-METTL3-Trib1 pathway attenuates lesion volume and alleviates pain. The most promising strategy appears to be combined therapy with autologous M1 macrophages and a mifepristone nanocarrier, which displays synergistic efficacy. Consequently, peritoneal macrophage polarisation constitutes a pivotal element of endometriosis pathogenesis; its targeted modulation represents an innovative, pathogenetically grounded approach that could enhance treatment efficacy and reduce recurrence rates, although further experimental and clinical studies are required for successful clinical translation.